D000276Chemicals & DrugsD27.505.696.477.06715260.989079Adjuvants, ImmunologicFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson21291323Bosch RJ, Pollard RB, Landay A, Aga E, Fox L, Mitsuyasu RJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine ResearchA randomized trial of interleukin-2 during withdrawal of antiretroviral treatment. J Interferon Cytokine Res. 2011 Jun; 31(6):481-3.J Interferon Cytokine Res2011-02-03T00:00:002011A randomized trial of interleukin-2 during withdrawal of antiretroviral treatment.19225080Wang Y, Blozis SA, Lederman M, Krieg A, Landay A, Miller CJClinical and vaccine immunology : CVIEnhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine. Clin Vaccine Immunol. 2009 Apr; 16(4):499-505.Clin Vaccine Immunol2009-02-18T00:00:002009Enhanced antibody responses elicited by a CpG adjuvant do not improve the protective effect of an aldrithiol-2-inactivated simian immunodeficiency virus therapeutic AIDS vaccine.true1ProfessorProfessorTiborGlantTibor Glant41.87386750000000-87.67102690000000349069Glant, TiborProfessorCharmaneEastmanCharmane Eastman349254Eastman, CharmaneProfessorDavidWilliamsDavid Lee Williams349574Williams, DavidAssociate ProfessorJoelBlockJoel Block349607Block, JoelProfessor5Associate Professor4Professor15146438Hanyecz A, Berlo SE, Sz?nt? S, Broeren CP, Mikecz K, Glant TTArthritis and rheumatismAchievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Arthritis Rheum. 2004 May; 50(5):1665-76.Arthritis Rheum2004-05-01T00:00:002004Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype.0.4604350.02623715research area of0.8629020.050801922subject area forOrthopedic SurgeryBehavioral SciencesRush University, Rush Medical CollegeAlanLandayAlan L. Landay41.87386750000000-87.67102690000000349009Landay, AlanProfessor35148840Borriello F, Poli V, Shrock E, Spreafico R, Liu X, Pishesha N, Carpenet C, Chou J, Di Gioia M, McGrath ME, Dillen CA, Barrett NA, Lacanfora L, Franco ME, Marongiu L, Iwakura Y, Pucci F, Kruppa MD, Ma Z, Lowman DW, Ensley HE, Nanishi E, Saito Y, O'Meara TR, Seo HS, Dhe-Paganon S, Dowling DJ, Frieman M, Elledge SJ, Levy O, Irvine DJ, Ploegh HL, Williams DL, Zanoni ICellAn adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity. Cell. 2022 02 17; 185(4):614-629.e21.Cell2022-02-10T00:00:002022An adjuvant strategy enabled by modulation of the physical properties of microbial ligands expands antigen immunogenicity.32371255Han B, Baruah K, Nguyen DV, Williams DL, Devriendt B, Cox E, Bossier PFish & shellfish immunologyBeta-glucan's varying structure characteristics modulate survival and immune-related genes expression from Vibrio harveyi-infected Artemia franciscana in gnotobiotic conditions. Fish Shellfish Immunol. 2020 Jul; 102:307-315.Fish Shellfish Immunol2020-05-03T00:00:002020Beta-glucan's varying structure characteristics modulate survival and immune-related genes expression from Vibrio harveyi-infected Artemia franciscana in gnotobiotic conditions.true1ProfessorProfessortrue1ProfessorProfessorInternal Medicine, Division of Geriatrics, Gerontology and Palliative MedicineInternal Medicine, Division of Rheumatologytrue1Associate ProfessorAssociate ProfessorMicrobial Pathogens and Immunitytrue1ProfessorProfessor